{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T01:29:07Z","timestamp":1788571747512,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81603460"],"award-info":[{"award-number":["81603460"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"Postdoctoral Science Foundation of China","doi-asserted-by":"crossref","award":["2015 M581533"],"award-info":[{"award-number":["2015 M581533"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Coronary heart disease (CHD) is a clinical syndrome caused by coronary atherosclerosis (AS) or functional changes in coronary arteries. We have previously reported that astragaloside IV (in astragalus) and tanshinone IIA (in\n                      <jats:italic>Salvia miltiorrhiza<\/jats:italic>\n                      ) improve myocardial ischemic injury.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study will employ the randomized, blinded, prospective, single-center experiments approach. Briefly, a total of 160 eligible patients will be equally randomized into three treatment groups and placebo control groups. Patients will receive appropriate treatments every 24\u2009h for seven\u2009days after enrollment and followed up for 28\u2009days. The main evaluation indicators will be cell count, serum high-sensitivity C-reactive protein (hs-CRP) level, monocyte chemoattractant protein 1 (MCP-1), interleukin-6 (IL-6), interleukin-1\u03b2 (IL-1\u03b2), interleukin-8 (IL-8), interleukin-18 (IL-18), interleukin-10 (IL-10), tumor necrosis factor (TNF)-\u03b1, oxidized low density lipoprotein (OX-LDL), angina grade, and Traditional Chinese Medicine (TCM) symptom changes scale. Secondary indicators to be evaluated will include B-type natriuretic peptide (BNP) levels, troponin (cTn), muscle enzyme isoenzyme (CK-MB), heart-type fatty acid binding protein (H-FABP), liver and renal functions, as well as blood coagulation. Close monitoring of adverse events during the trial will also be conducted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This randomized controlled trial of Chinese herbal extracts for the treatment of coronary heart disease will generate results that are expected to provide valuable clinical evidence to inform future development of therapies towards management of CHD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      China Clinical Trial Registration Center,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/searchproj.aspx\">ChiCTR1900021590<\/jats:ext-link>\n                      . Registered on 28 February 2019.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-020-4109-6","type":"journal-article","created":{"date-parts":[[2020,3,16]],"date-time":"2020-03-16T23:02:54Z","timestamp":1584399774000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effects of Astragalus injection and Salvia Miltiorrhiza injection on serum inflammatory markers in patients with stable coronary heart disease: a randomized controlled trial protocol"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhihao","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2199-2999","authenticated-orcid":false,"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"1","key":"4109_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.5114\/aoms.2015.50772","volume":"12","author":"A Matusiak","year":"2016","unstructured":"Matusiak A, Cha\u0142ubi\u0144ski M, Broncel M, Rechci\u0144ski T, Rudnicka K, Miszczyk E, et al. Putative consequences of exposure to Helicobacter pylori infection in patients with coronary heart disease in terms of humoral immune response and inflammation. Arch Med Sci. 2016;12(1):45\u201354.","journal-title":"Arch Med Sci"},{"issue":"8","key":"4109_CR2","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1039\/C7FO00204A","volume":"8","author":"D Fan","year":"2017","unstructured":"Fan D, Yang Z, Yuan Y, Wu QQ, Xu M, Jin YG, et al. Sesamin prevents apoptosis and inflammation after experimental myocardial infarction by JNK and NF-\u03baB pathways. Food Funct. 2017;8(8):2875\u201385.","journal-title":"Food Funct"},{"issue":"1","key":"4109_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1423-0127-19-79","volume":"19","author":"LJ Chen","year":"2012","unstructured":"Chen LJ, Lim SH, Yeh YT, Lien SC, Chiu JJ. Roles of microRNAs in atherosclerosis and restenosis. J Biomed Sci. 2012;19(1):79.","journal-title":"J Biomed Sci"},{"issue":"02","key":"4109_CR4","first-page":"225","volume":"26","author":"Y Guo","year":"2017","unstructured":"Guo Y, Zhou W, Luo Y, Zhang D. Research progress on the relationship between high-sensitivity C-reactive protein and coronary heart disease. J Cardiovasc Rehabil Med. 2017;26(02):225\u20137 Article in Chinese.","journal-title":"J Cardiovasc Rehabil Med"},{"issue":"3","key":"4109_CR5","first-page":"409","volume":"21","author":"X Chen","year":"2017","unstructured":"Chen X. Changes of serum troponin T and high-sensitivity C-reactive protein levels in patients with coronary heart disease before and after interventional therapy and their correlation with prognosis. Chin Lab Diagn. 2017;21(3):409\u201310 Article in Chinese.","journal-title":"Chin Lab Diagn"},{"issue":"2","key":"4109_CR6","first-page":"156","volume":"40","author":"Q Feng","year":"2017","unstructured":"Feng Q. Clinical significance of correlation between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and D-dimer and coronary heart disease patients. Int J Immunol. 2017;40(2):156\u201360 Article in Chinese.","journal-title":"Int J Immunol"},{"issue":"9","key":"4109_CR7","first-page":"1440","volume":"32","author":"Z Qiu","year":"2016","unstructured":"Qiu Z, Lu D. Effect of continuous positive airway pressure on hypersensitive C-reactive protein in patients with coronary heart disease complicated with obstructive sleep apnea. J Pract Med. 2016;32(9):1440\u20132 Article in Chinese.","journal-title":"J Pract Med"},{"issue":"10","key":"4109_CR8","first-page":"920","volume":"48","author":"J Wang","year":"2007","unstructured":"Wang J, Li J, Yao H. Study on the syndrome elements and syndrome combination of angina pectoris. Chin Med J. 2007;48(10):920\u20132 Article in Chinese.","journal-title":"Chin Med J"},{"issue":"3","key":"4109_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/1535370213517620","volume":"239","author":"Q Liu","year":"2014","unstructured":"Liu Q, Wang J, Liang Q, Wang D, Luo Y, Li J, et al. Sparstolonin B attenuates hypoxia-reoxygenation-induced cardiomyocyte inflammation. Exp Biol Med (Maywood). 2014;239(3):376\u201384.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"4109_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s10557-014-6545-6","volume":"28","author":"Q Liu","year":"2014","unstructured":"Liu Q, Li J, Jubair S, Wang D, Luo Y, Fan D, et al. Sparstolonin B attenuates hypoxia-induced apoptosis, necrosis and inflammation in cultured rat left ventricular tissue slices. Cardiovasc Drugs Ther. 2014;28(5):433\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"key":"4109_CR11","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.vph.2015.03.015","volume":"67","author":"Q Liu","year":"2015","unstructured":"Liu Q, Li J, Liang Q, Wang D, Luo Y, Yu F, et al. Sparstolonin B suppresses rat vascular smooth muscle cell proliferation, migration, inflammatory response and lipid accumulation. Vascul Pharmacol. 2015;67:59\u201366.","journal-title":"Vascul Pharmacol"},{"key":"4109_CR12","first-page":"925625","volume":"2013","author":"Q Liu","year":"2013","unstructured":"Liu Q, Li J, Wang J, Li J, Janicki JS, Fan D. Effects and mechanisms of chinese herbal medicine in ameliorating myocardial ischemia-reperfusion injury. Evid Based Complement Alternat Med. 2013;2013:925625.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4109_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jep.2017.03.053","volume":"204","author":"D Wang","year":"2017","unstructured":"Wang D, Liu Y, Zhong G, Wang Y, Zhang T, Zhao Z, et al. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury. J Ethnopharmacol. 2017;204:67\u201376.","journal-title":"J Ethnopharmacol"},{"key":"4109_CR14","unstructured":"Wang Y. Analysis of Clinical Pharmacology and Combination of Danshen injection and Huangqi injection. Chin Pract Med. 2016;11(09):192\u20133. Article in Chinese."},{"issue":"3","key":"4109_CR15","first-page":"195","volume":"35","author":"Cardiovascular Branch of Chinese Medical Association","year":"2007","unstructured":"Cardiovascular Branch of Chinese Medical Association. Guidelines for the diagnosis and treatment of chronic stable angina pectoris. Chin J Cardiovasc Dis. 2007;35(3):195\u2013206 Article in Chinese.","journal-title":"Chin J Cardiovasc Dis"},{"issue":"21","key":"4109_CR16","first-page":"2284","volume":"24","author":"Q Li","year":"2015","unstructured":"Li Q, Gan S, Huang H. Effect of sodium tanshinone IIA sulfonate on acute coronary syndrome and its effect on inflammatory factors. Mod J Integr Tradit Chin West Med. 2015;24(21):2284\u20136 Article in Chinese.","journal-title":"Mod J Integr Tradit Chin West Med"},{"issue":"21","key":"4109_CR17","first-page":"2528","volume":"14","author":"J Ma","year":"2016","unstructured":"Ma J, Liang X. Effect of salvia miltiorrhiza injection on serum homocysteine, folic acid and C-reactive protein levels in ST-segment elevation acute myocardial death patients. Chin J Integr Tradit West Med. 2016;14(21):2528\u201330 Article in Chinese.","journal-title":"Chin J Integr Tradit West Med"},{"issue":"38","key":"4109_CR18","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"issue":"7","key":"4109_CR19","first-page":"786","volume":"13","author":"Y Lv","year":"2008","unstructured":"Lv Y, He Y, Yang J. Study on symptom scores of coronary heart disease with angina pectoris (qi deficiency and blood stasis syndrome). Chin Clini Pharmacol Ther. 2008;13(7):786\u201391 Article in Chinese.","journal-title":"Chin Clini Pharmacol Ther"},{"issue":"15","key":"4109_CR20","first-page":"7","volume":"24","author":"Chinese Medicine Association and Cardiovascular Disease Club","year":"2017","unstructured":"Chinese Medicine Association and Cardiovascular Disease Club. Evaluation criteria for medical efficacy in angina pectoris. Chin J Exp Tradit Med Formulae. 2017;24(15):7\u201310 Article in Chinese.","journal-title":"Chin J Exp Tradit Med Formulae"},{"key":"4109_CR21","first-page":"227","volume-title":"Internal medicine","author":"J Ge","year":"2013","unstructured":"Ge J, Xu Y. Internal medicine. Beijing: People\u2019s Health Publishing House; 2013. p. 227\u20138. Article in Chinese."},{"issue":"22","key":"4109_CR22","first-page":"11","volume":"4","author":"Y Yang","year":"2016","unstructured":"Yang Y. A review of the current status and research progress of interventional therapy for coronary heart disease. Chin J Integr Tradit West Cardiol. 2016;4(22):11\u20132 Article in Chinese.","journal-title":"Chin J Integr Tradit West Cardiol"},{"issue":"07","key":"4109_CR23","first-page":"841","volume":"30","author":"Y Lan","year":"2015","unstructured":"Lan Y, Chen X. Clinical study of ulinastatin combined with astragalus injection in the treatment of inflammatory reaction after PCI in patients with myocardial infarction. Drugs Clin. 2015;30(07):841\u20135 Article in Chinese.","journal-title":"Drugs Clin"},{"issue":"25","key":"4109_CR24","doi-asserted-by":"publisher","first-page":"e572","DOI":"10.1161\/01.CIR.0000148986.52696.07","volume":"110","author":"WL Roberts","year":"2004","unstructured":"Roberts WL. CDC\/AHA workshop on markers of inflammation and cardiovascular disease: application to clinical and public health practice: laboratory tests available to assess inflammation--performance and standardization: a background paper. Circulation. 2004;110(25):e572\u20136.","journal-title":"Circulation"},{"issue":"9","key":"4109_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/eurheartj\/eht367","volume":"35","author":"S Kaptoge","year":"2014","unstructured":"Kaptoge S, Seshasai SR, Gao P, Freitag DF, Butterworth AS, Borglykke A, et al. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur Heart J. 2014;35(9):578\u201389.","journal-title":"Eur Heart J"},{"issue":"2","key":"4109_CR26","first-page":"169","volume":"25","author":"Y Qu","year":"2014","unstructured":"Qu Y, Wang D, Yan X. Effect of astragaloside on autophagy in neonatal rat cardiomyocytes and inhibition of apoptosis induced by ischemia-induced cardiomyocytes. Tradit Chin Med Clin Pharmacol. 2014;25(2):169\u201372 Article in Chinese.","journal-title":"Tradit Chin Med Clin Pharmacol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-020-4109-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-020-4109-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T20:29:15Z","timestamp":1615926555000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-020-4109-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4109"],"URL":"https:\/\/doi.org\/10.1186\/s13063-020-4109-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12889\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12889\/v2","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"9 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This trial complies with the principles of Declaration of Helsinki and the regulations of quality management of clinical trials in China. The research activities in this trial have been approved by the Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine. The committee\u2019s reference number is BF2018\u2013182-01 (Table\n                      \n                      ). All study participants will sign written ICFs before participating in the trial.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}